[e-drug] Pharmacy lobby opposes survey regarding Medicaid prices

E-DRUG: Pharmacy lobby opposes survey regarding Medicaid prices
-------------------------------------

From Kaiser Health News, Aug. 12, 2010:

referencing original article from The Hill:

Pharmacies, drugstores object to Medicaid price transparency effort
http://thehill.com/blogs/healthwatch/medicaid/113811-pharmacies-drugstores-object-to-medicaid-price-transparency-effort

The pharmacy and drugstore lobbies are strongly objecting to a new effort by the federal government to gather more data on drug prices in the Medicaid program.

The groups say the Centers for Medicare and Medicaid Services (CMS) exceeded its legal authority when it recently put out a request for proposal requiring a "nationwide survey of consumer purchase prices" for drugs at retail pharmacies that participate in Medicaid.

"CMS does not have the authority to post individual (retail survey prices), and is only authorized by (the health reform law) to post an 'average retail survey price'," the groups write in a letter sent Friday to Cindy Mann, director of the CMS Center for Medicaid, CHIP and Survey & Certification. The letter, obtained by The Hill, is signed by the American Pharmacists Association, the National Association of Chain Drug Stores, the National Community Pharmacists Association and the Food Marketing Institute.

"Furthermore," the letter continues, "we are greatly troubled by (a requirement in the request for proposal) which asks a contractor to collect and disclose wholesale prices that pharmacies pay to purchase drugs. We have identified no legal authority for CMS to collect and distribute pharmacy acquisition data."...............

-----------------
Joana Ramos, MSW
Cancer Resources & Advocacy
Seattle WA USA
+1-206-229-2420
http://ramoslink.info/
www.bmtbasics.org

jdr@ramoslink.info

E-DRUG: Pharmacy lobby opposes survey regarding Medicaid prices (2)
------------------------------------------------

Hi,

Why the opposition from the phamacy lobby to the transparency in medicine prices? What is it that they want to keep confidential if
survey of consumer purchase prices for medicines at retail pharmacies is carried and the results are made public?

The public has a right to know what, how much, to whom, where is being charged from them for medicines and why? Gone is the age when secrecy in trade prices was practiced. Current times demand openness and transparency in prices to ensure that reasonable profits are charged from them and profiteering does not exist in medicines.

If there is any law in any land, which prevents public from having access to medicine pricing information, it is outdated and needs immediate amendment in public interest. The interest of public is supreme and can not be undermined, sacrificed to appease the interest of business.

Dr Vijay Thawani, Nagpur, India
vijaythawani@rediffmail.com

------------------------------------------------
Join in Network for Rational Use of Medicines (NetRUM) free E-discussions at: http://health.groups.yahoo.com/group/netrum

RESEARCH METHODOLOGY: SEGMENT II : METHODOLOGY

25-28 Aug: Data analysis, interpretation and drawing inferences; Moderator Dr Arin Basu

1-3 Sep: Documentation in research; Moderator Dr Anupama Sukhlecha

Dr Vijay Thawani
Group Owner, NetRUM